HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Motoi Hosoe Selected Research

Mometasone Furoate (Nasonex)

5/2022Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week studies.
1/2022A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma.
10/2021Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers.
4/2021Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
1/2021Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population.
1/2021One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies.
10/2020Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study.
1/2020A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Motoi Hosoe Research Topics

Disease

9Asthma (Bronchial Asthma)
05/2022 - 11/2010
3Chronic Obstructive Pulmonary Disease (COPD)
02/2012 - 09/2010
1Dysphonia (Spastic Dysphonia)
05/2022

Drug/Important Bio-Agent (IBA)

12indacaterolIBA
05/2022 - 09/2010
8Mometasone Furoate (Nasonex)FDA LinkGeneric
05/2022 - 01/2020
7Acetates (Acetic Acid Esters)FDA Link
05/2022 - 10/2020
7Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 11/2010
5Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
05/2022 - 10/2020
3IridiumIBA
01/2021 - 10/2020
2Pharmaceutical PreparationsIBA
05/2022 - 01/2022
2Muscarinic AntagonistsIBA
01/2022 - 04/2021
2Salmeterol Xinafoate (Serevent)FDA Link
01/2021 - 11/2010
2Fluticasone-Salmeterol Drug Combination (Advair)FDA Link
01/2021 - 10/2020
2Bronchodilator Agents (Bronchodilators)IBA
11/2010 - 09/2010
1QMF149IBA
10/2021
1PalladiumIBA
01/2021
1Fluticasone (Cutivate)FDA LinkGeneric
01/2021
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
10/2020

Therapy/Procedure

4Nebulizers and Vaporizers (Inhaler)
01/2022 - 10/2020
2Therapeutics
01/2022 - 01/2021
1Dry Powder Inhalers
09/2010